Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacoeconomics and Outcomes Research

Bakst A, Meletiche D, Arnold R, et al. The Avandia Worldwide Awareness Registry (AWARe ) an Internet-based program for evaluation of clinical, humanistic and economic outcomes of patients with type 2 diabetes. International Society for Pharmacoeconomics and Outcomes Research Sixth Annual International Meeting. Philadelphia, Pennsylvania, 2001. [Pg.588]

International Society for Pharmacoeconomic and Outcomes Research (ISPOR)... [Pg.422]

Other, more complex terms are defined and described in standard textbooks of epidemiology and statistics (q.v.) and included in two excellent lexicons, the Dictionary of Epidemiology (Last, 2001) and, more recently, a very useful Lexicon from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). [Pg.307]

ISPOR—International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, New Jersey, U.S.A. [Pg.488]

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, 501(c)(3) member organization governed by an annually elected board of directors, with administrative headquarters located in the heart of central New Jersey s pharmaceutical corridor. (3100 Princeton Pike, Building 3, Suite D, Lawrenceville, New Jersey 08648 Tel 609-219-0773 Fax 609-219-0774. Its mission is to translate research and outcomes/results in pharmacoeconomics into practice to ensure fair and efficient distribution of healthcare resources. [Pg.488]

With a steadily growing membership of 2000 representing 29 countries, ISPOR remains steadfast in its mission to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce healthcare resources wisely, fairly, and efficiently. The Society serves the public interest by ... [Pg.488]

Pharmacoeconomics and Outcomes Research Curriculum Development, North America. [Pg.489]

Currently, ISPOR initiatives include developing standards of research practices to guide the activities of those conducting pharmacoeconomics and outcomes research, and developing educational programs to communicate those research results to healthcare decision makers who could greatly benefit from it. [Pg.489]

LEXICON—a unique dictionary of pharmacoeconomics and outcomes research terminology. [Pg.489]

The Annual International Meeting (generally held in May each year) and Annual European Conference (generally held in November or December each year)— promote the discipline of pharmacoeconomics and outcomes research through networking and education. [Pg.489]

International Society for Pharmacoeconomics and Outcomes Research, ISPOR Lexicon Pashos, Klein, Wanke, L.A., Eds. ISPOR New Jersey, 1998. Spilker, B. In Quality of Life and Pharmacoeconomics in Clinical Trials 2nd Ed. Spilker, B., Eds. Lippincott-Raven Philadelphia, PA, 1996. [Pg.704]

Bootman JL. Pharmacoeconomics and outcomes research. Am J Health System Pharm 1995 52(suppl 3) S16-S19. [Pg.13]


See other pages where Pharmacoeconomics and Outcomes Research is mentioned: [Pg.741]    [Pg.741]    [Pg.742]    [Pg.742]    [Pg.244]    [Pg.488]    [Pg.488]    [Pg.489]    [Pg.618]    [Pg.195]    [Pg.526]    [Pg.527]    [Pg.527]   


SEARCH



International Society for Pharmacoeconomics and Outcomes Research

Outcomes research

Pharmacoeconomic

Pharmacoeconomic research

Pharmacoeconomics outcomes

Pharmacoeconomics outcomes research

© 2024 chempedia.info